Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
GlobalData
Pharma
Novo, Lilly lost value in Q3 while BMS, Gilead and Sanofi surged
While Eli Lilly and Novo Nordisk experienced market cap declines in Q3, BMS, Gilead and Sanofi saw their value increase, according to GlobalData.
Kevin Dunleavy
Nov 8, 2024 5:00am
AbbVie's Ubrelvy to be top migraine seller in 2033
Sep 10, 2024 7:15am
Madrigal tipped to target scientific events to boost MASH growth
Aug 12, 2024 8:15am
New CKD drugs are promising, but not yet disruptive: report
Jun 26, 2024 10:45am
Biopharma bubbly as falling inflation, rising funding ease woes
Jun 10, 2024 11:59am
Arrowhead's plozasiran could reach $700M-plus in sales: report
Apr 16, 2024 3:05pm
